Pharmaron (康龙化成) A+H: Allocation and Thoughts on Trading
Pharmaron, the second-largest contract research organization (CRO), raised USD 560 m at HKD 39.50/share. In this insight, we will cover the...
427 Views
ECM Weekly (24 Nov 2019) - Alibaba, OneConnect, Tyro Payments, New Frontier Corp, AlphaMab
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Asia ECM...
446 Views
ECM Weekly (16 Nov 2019) - Alibaba, Freee, Megvii, Pharmaron, Canaan, XD
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Even as...
404 Views
Pharmaron Beijing IPO: H-Share Valuation Enticing
Pharmaron Beijing Co Ltd-H (3759 HK) is a global contract research organisation (CRO) and is one of the top three drug discovery service providers...
575 Views
Pharmaron (康龙化成) A+H: Decent H/A Discount and Cornerstone Line-Up
Pharmaron, the secondly largest CRO based in China, launched book building today to raise up to USD 588 million to list in Hong Kong. In our...
556 Views